HEADER TRANSCRIPTION 29-JUL-21 7FH2 TITLE CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF BRD4 IN COMPLEX WITH TITLE 2 16D10 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 4; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: PROTEIN HUNK1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRD4, HUNK1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, BROMODOMAIN, BRD4, HISTONE, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR T.YOKOYAMA,N.HIRASAWA REVDAT 3 29-NOV-23 7FH2 1 REMARK REVDAT 2 21-DEC-22 7FH2 1 JRNL REVDAT 1 03-AUG-22 7FH2 0 JRNL AUTH R.SEGAWA,H.TAKEDA,T.YOKOYAMA,M.ISHIDA,C.MIYATA,T.SAITO, JRNL AUTH 2 R.ISHIHARA,T.NAKAGITA,Y.SASANO,N.KANOH,Y.IWABUCHI, JRNL AUTH 3 M.MIZUGUCHI,M.HIRATSUKA,N.HIRASAWA JRNL TITL A CHALCONE DERIVATIVE SUPPRESSES TSLP INDUCTION IN MICE AND JRNL TITL 2 HUMAN KERATINOCYTES THROUGH BINDING TO BET FAMILY PROTEINS. JRNL REF BIOCHEM PHARMACOL V. 194 14819 2021 JRNL REFN ISSN 1873-2968 JRNL PMID 34757034 JRNL DOI 10.1016/J.BCP.2021.114819 REMARK 2 REMARK 2 RESOLUTION. 2.49 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.12_2829: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.49 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.63 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 21669 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.255 REMARK 3 R VALUE (WORKING SET) : 0.253 REMARK 3 FREE R VALUE : 0.293 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.030 REMARK 3 FREE R VALUE TEST SET COUNT : 1090 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 19.6300 - 4.9606 0.98 2711 144 0.2120 0.2486 REMARK 3 2 4.9606 - 3.9479 0.99 2637 139 0.2086 0.2502 REMARK 3 3 3.9479 - 3.4519 0.99 2591 138 0.2359 0.2665 REMARK 3 4 3.4519 - 3.1377 0.99 2583 136 0.2904 0.3079 REMARK 3 5 3.1377 - 2.9136 0.98 2536 134 0.3018 0.3448 REMARK 3 6 2.9136 - 2.7423 0.98 2553 136 0.3179 0.3727 REMARK 3 7 2.7423 - 2.6053 0.98 2503 131 0.3446 0.4169 REMARK 3 8 2.6053 - 2.4921 0.95 2465 132 0.3933 0.4318 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.300 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 39.520 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 3969 REMARK 3 ANGLE : 0.626 5394 REMARK 3 CHIRALITY : 0.057 566 REMARK 3 PLANARITY : 0.004 680 REMARK 3 DIHEDRAL : 17.044 1542 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: (CHAIN D) AND (RESIDUES 61:164) REMARK 3 ORIGIN FOR THE GROUP (A): 11.618 0.485 10.533 REMARK 3 T TENSOR REMARK 3 T11: 0.5736 T22: 0.7099 REMARK 3 T33: 0.3891 T12: -0.0551 REMARK 3 T13: -0.0008 T23: 0.0091 REMARK 3 L TENSOR REMARK 3 L11: 1.1482 L22: 0.4157 REMARK 3 L33: 2.0946 L12: -0.1336 REMARK 3 L13: -0.4707 L23: 0.0317 REMARK 3 S TENSOR REMARK 3 S11: -0.0807 S12: -0.0615 S13: -0.0710 REMARK 3 S21: -0.0214 S22: 0.0377 S23: 0.0336 REMARK 3 S31: 0.1648 S32: -0.0160 S33: 0.0601 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7FH2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 31-JUL-21. REMARK 100 THE DEPOSITION ID IS D_1300023590. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-DEC-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-17A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21984 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.490 REMARK 200 RESOLUTION RANGE LOW (A) : 47.530 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 10.90 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.49 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.58 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 6AJW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.19 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 13.4 MG/ML BRD4-BD1, 0.5 MM 16D10, 20% REMARK 280 PEG 3350, 0.1 M BIS-TRIS PH 6.5, 0.2 M AMMONIUM SULFATE, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.50500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.40150 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.93800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 55.40150 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.50500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.93800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 34 REMARK 465 HIS A 35 REMARK 465 HIS A 36 REMARK 465 HIS A 37 REMARK 465 HIS A 38 REMARK 465 HIS A 39 REMARK 465 HIS A 40 REMARK 465 MET A 41 REMARK 465 SER A 42 REMARK 465 ASN A 54 REMARK 465 LYS A 55 REMARK 465 PRO A 56 REMARK 465 LYS A 57 REMARK 465 ARG A 58 REMARK 465 THR A 166 REMARK 465 GLU A 167 REMARK 465 GLU A 168 REMARK 465 MET B 34 REMARK 465 HIS B 35 REMARK 465 HIS B 36 REMARK 465 HIS B 37 REMARK 465 HIS B 38 REMARK 465 HIS B 39 REMARK 465 HIS B 40 REMARK 465 MET B 41 REMARK 465 SER B 42 REMARK 465 ASN B 54 REMARK 465 LYS B 55 REMARK 465 PRO B 56 REMARK 465 LYS B 57 REMARK 465 ARG B 58 REMARK 465 GLN B 59 REMARK 465 GLU B 167 REMARK 465 GLU B 168 REMARK 465 MET C 34 REMARK 465 HIS C 35 REMARK 465 HIS C 36 REMARK 465 HIS C 37 REMARK 465 HIS C 38 REMARK 465 HIS C 39 REMARK 465 HIS C 40 REMARK 465 MET C 41 REMARK 465 SER C 42 REMARK 465 THR C 43 REMARK 465 ASN C 44 REMARK 465 PRO C 45 REMARK 465 PRO C 46 REMARK 465 PRO C 47 REMARK 465 PRO C 48 REMARK 465 GLU C 49 REMARK 465 THR C 50 REMARK 465 SER C 51 REMARK 465 ASN C 52 REMARK 465 PRO C 53 REMARK 465 ASN C 54 REMARK 465 LYS C 55 REMARK 465 PRO C 56 REMARK 465 LYS C 57 REMARK 465 ARG C 58 REMARK 465 GLN C 59 REMARK 465 THR C 60 REMARK 465 GLU C 167 REMARK 465 GLU C 168 REMARK 465 MET D 34 REMARK 465 HIS D 35 REMARK 465 HIS D 36 REMARK 465 HIS D 37 REMARK 465 HIS D 38 REMARK 465 HIS D 39 REMARK 465 HIS D 40 REMARK 465 MET D 41 REMARK 465 SER D 42 REMARK 465 THR D 43 REMARK 465 ASN D 44 REMARK 465 PRO D 45 REMARK 465 PRO D 46 REMARK 465 PRO D 47 REMARK 465 PRO D 48 REMARK 465 GLU D 49 REMARK 465 THR D 50 REMARK 465 SER D 51 REMARK 465 ASN D 52 REMARK 465 PRO D 53 REMARK 465 ASN D 54 REMARK 465 LYS D 55 REMARK 465 PRO D 56 REMARK 465 LYS D 57 REMARK 465 ARG D 58 REMARK 465 GLN D 59 REMARK 465 THR D 60 REMARK 465 PRO D 165 REMARK 465 THR D 166 REMARK 465 GLU D 167 REMARK 465 GLU D 168 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS B 72 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 69 -57.42 -122.56 REMARK 500 VAL B 69 -58.92 -120.96 REMARK 500 VAL C 69 -55.93 -124.86 REMARK 500 VAL D 69 -58.50 -123.24 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH C 310 DISTANCE = 7.30 ANGSTROMS DBREF 7FH2 A 42 168 UNP O60885 BRD4_HUMAN 42 168 DBREF 7FH2 B 42 168 UNP O60885 BRD4_HUMAN 42 168 DBREF 7FH2 C 42 168 UNP O60885 BRD4_HUMAN 42 168 DBREF 7FH2 D 42 168 UNP O60885 BRD4_HUMAN 42 168 SEQADV 7FH2 MET A 34 UNP O60885 INITIATING METHIONINE SEQADV 7FH2 HIS A 35 UNP O60885 EXPRESSION TAG SEQADV 7FH2 HIS A 36 UNP O60885 EXPRESSION TAG SEQADV 7FH2 HIS A 37 UNP O60885 EXPRESSION TAG SEQADV 7FH2 HIS A 38 UNP O60885 EXPRESSION TAG SEQADV 7FH2 HIS A 39 UNP O60885 EXPRESSION TAG SEQADV 7FH2 HIS A 40 UNP O60885 EXPRESSION TAG SEQADV 7FH2 MET A 41 UNP O60885 EXPRESSION TAG SEQADV 7FH2 MET B 34 UNP O60885 INITIATING METHIONINE SEQADV 7FH2 HIS B 35 UNP O60885 EXPRESSION TAG SEQADV 7FH2 HIS B 36 UNP O60885 EXPRESSION TAG SEQADV 7FH2 HIS B 37 UNP O60885 EXPRESSION TAG SEQADV 7FH2 HIS B 38 UNP O60885 EXPRESSION TAG SEQADV 7FH2 HIS B 39 UNP O60885 EXPRESSION TAG SEQADV 7FH2 HIS B 40 UNP O60885 EXPRESSION TAG SEQADV 7FH2 MET B 41 UNP O60885 EXPRESSION TAG SEQADV 7FH2 MET C 34 UNP O60885 INITIATING METHIONINE SEQADV 7FH2 HIS C 35 UNP O60885 EXPRESSION TAG SEQADV 7FH2 HIS C 36 UNP O60885 EXPRESSION TAG SEQADV 7FH2 HIS C 37 UNP O60885 EXPRESSION TAG SEQADV 7FH2 HIS C 38 UNP O60885 EXPRESSION TAG SEQADV 7FH2 HIS C 39 UNP O60885 EXPRESSION TAG SEQADV 7FH2 HIS C 40 UNP O60885 EXPRESSION TAG SEQADV 7FH2 MET C 41 UNP O60885 EXPRESSION TAG SEQADV 7FH2 MET D 34 UNP O60885 INITIATING METHIONINE SEQADV 7FH2 HIS D 35 UNP O60885 EXPRESSION TAG SEQADV 7FH2 HIS D 36 UNP O60885 EXPRESSION TAG SEQADV 7FH2 HIS D 37 UNP O60885 EXPRESSION TAG SEQADV 7FH2 HIS D 38 UNP O60885 EXPRESSION TAG SEQADV 7FH2 HIS D 39 UNP O60885 EXPRESSION TAG SEQADV 7FH2 HIS D 40 UNP O60885 EXPRESSION TAG SEQADV 7FH2 MET D 41 UNP O60885 EXPRESSION TAG SEQRES 1 A 135 MET HIS HIS HIS HIS HIS HIS MET SER THR ASN PRO PRO SEQRES 2 A 135 PRO PRO GLU THR SER ASN PRO ASN LYS PRO LYS ARG GLN SEQRES 3 A 135 THR ASN GLN LEU GLN TYR LEU LEU ARG VAL VAL LEU LYS SEQRES 4 A 135 THR LEU TRP LYS HIS GLN PHE ALA TRP PRO PHE GLN GLN SEQRES 5 A 135 PRO VAL ASP ALA VAL LYS LEU ASN LEU PRO ASP TYR TYR SEQRES 6 A 135 LYS ILE ILE LYS THR PRO MET ASP MET GLY THR ILE LYS SEQRES 7 A 135 LYS ARG LEU GLU ASN ASN TYR TYR TRP ASN ALA GLN GLU SEQRES 8 A 135 CYS ILE GLN ASP PHE ASN THR MET PHE THR ASN CYS TYR SEQRES 9 A 135 ILE TYR ASN LYS PRO GLY ASP ASP ILE VAL LEU MET ALA SEQRES 10 A 135 GLU ALA LEU GLU LYS LEU PHE LEU GLN LYS ILE ASN GLU SEQRES 11 A 135 LEU PRO THR GLU GLU SEQRES 1 B 135 MET HIS HIS HIS HIS HIS HIS MET SER THR ASN PRO PRO SEQRES 2 B 135 PRO PRO GLU THR SER ASN PRO ASN LYS PRO LYS ARG GLN SEQRES 3 B 135 THR ASN GLN LEU GLN TYR LEU LEU ARG VAL VAL LEU LYS SEQRES 4 B 135 THR LEU TRP LYS HIS GLN PHE ALA TRP PRO PHE GLN GLN SEQRES 5 B 135 PRO VAL ASP ALA VAL LYS LEU ASN LEU PRO ASP TYR TYR SEQRES 6 B 135 LYS ILE ILE LYS THR PRO MET ASP MET GLY THR ILE LYS SEQRES 7 B 135 LYS ARG LEU GLU ASN ASN TYR TYR TRP ASN ALA GLN GLU SEQRES 8 B 135 CYS ILE GLN ASP PHE ASN THR MET PHE THR ASN CYS TYR SEQRES 9 B 135 ILE TYR ASN LYS PRO GLY ASP ASP ILE VAL LEU MET ALA SEQRES 10 B 135 GLU ALA LEU GLU LYS LEU PHE LEU GLN LYS ILE ASN GLU SEQRES 11 B 135 LEU PRO THR GLU GLU SEQRES 1 C 135 MET HIS HIS HIS HIS HIS HIS MET SER THR ASN PRO PRO SEQRES 2 C 135 PRO PRO GLU THR SER ASN PRO ASN LYS PRO LYS ARG GLN SEQRES 3 C 135 THR ASN GLN LEU GLN TYR LEU LEU ARG VAL VAL LEU LYS SEQRES 4 C 135 THR LEU TRP LYS HIS GLN PHE ALA TRP PRO PHE GLN GLN SEQRES 5 C 135 PRO VAL ASP ALA VAL LYS LEU ASN LEU PRO ASP TYR TYR SEQRES 6 C 135 LYS ILE ILE LYS THR PRO MET ASP MET GLY THR ILE LYS SEQRES 7 C 135 LYS ARG LEU GLU ASN ASN TYR TYR TRP ASN ALA GLN GLU SEQRES 8 C 135 CYS ILE GLN ASP PHE ASN THR MET PHE THR ASN CYS TYR SEQRES 9 C 135 ILE TYR ASN LYS PRO GLY ASP ASP ILE VAL LEU MET ALA SEQRES 10 C 135 GLU ALA LEU GLU LYS LEU PHE LEU GLN LYS ILE ASN GLU SEQRES 11 C 135 LEU PRO THR GLU GLU SEQRES 1 D 135 MET HIS HIS HIS HIS HIS HIS MET SER THR ASN PRO PRO SEQRES 2 D 135 PRO PRO GLU THR SER ASN PRO ASN LYS PRO LYS ARG GLN SEQRES 3 D 135 THR ASN GLN LEU GLN TYR LEU LEU ARG VAL VAL LEU LYS SEQRES 4 D 135 THR LEU TRP LYS HIS GLN PHE ALA TRP PRO PHE GLN GLN SEQRES 5 D 135 PRO VAL ASP ALA VAL LYS LEU ASN LEU PRO ASP TYR TYR SEQRES 6 D 135 LYS ILE ILE LYS THR PRO MET ASP MET GLY THR ILE LYS SEQRES 7 D 135 LYS ARG LEU GLU ASN ASN TYR TYR TRP ASN ALA GLN GLU SEQRES 8 D 135 CYS ILE GLN ASP PHE ASN THR MET PHE THR ASN CYS TYR SEQRES 9 D 135 ILE TYR ASN LYS PRO GLY ASP ASP ILE VAL LEU MET ALA SEQRES 10 D 135 GLU ALA LEU GLU LYS LEU PHE LEU GLN LYS ILE ASN GLU SEQRES 11 D 135 LEU PRO THR GLU GLU HET 4JI A 201 30 HET CL A 202 1 HET 4JI B 201 30 HET 4JI B 202 30 HET CL B 203 1 HET CL C 201 1 HET 4JI D 201 30 HET CL D 202 1 HETNAM 4JI N-[2-[2-[(E)-3-(2,5-DIMETHOXYPHENYL)PROP-2-ENOYL]-4,5- HETNAM 2 4JI DIMETHOXY-PHENYL]ETHYL]ETHANAMIDE HETNAM CL CHLORIDE ION FORMUL 5 4JI 4(C23 H27 N O6) FORMUL 6 CL 4(CL 1-) FORMUL 13 HOH *42(H2 O) HELIX 1 AA1 THR A 60 VAL A 69 1 10 HELIX 2 AA2 VAL A 69 LYS A 76 1 8 HELIX 3 AA3 HIS A 77 GLN A 84 5 8 HELIX 4 AA4 ASP A 96 ILE A 101 1 6 HELIX 5 AA5 ASP A 106 ASN A 116 1 11 HELIX 6 AA6 ASN A 121 ASN A 140 1 20 HELIX 7 AA7 ASP A 144 ILE A 161 1 18 HELIX 8 AA8 ASN B 61 VAL B 69 1 9 HELIX 9 AA9 VAL B 69 LYS B 76 1 8 HELIX 10 AB1 HIS B 77 GLN B 84 5 8 HELIX 11 AB2 ASP B 96 ILE B 101 1 6 HELIX 12 AB3 ASP B 106 ASN B 116 1 11 HELIX 13 AB4 ASN B 121 ASN B 140 1 20 HELIX 14 AB5 ASP B 144 ASN B 162 1 19 HELIX 15 AB6 GLN C 62 VAL C 69 1 8 HELIX 16 AB7 VAL C 69 LYS C 76 1 8 HELIX 17 AB8 HIS C 77 GLN C 84 5 8 HELIX 18 AB9 ASP C 96 ILE C 101 1 6 HELIX 19 AC1 ASP C 106 ASN C 116 1 11 HELIX 20 AC2 ASN C 121 ASN C 140 1 20 HELIX 21 AC3 ASP C 144 ASN C 162 1 19 HELIX 22 AC4 GLN D 62 VAL D 69 1 8 HELIX 23 AC5 VAL D 69 LYS D 76 1 8 HELIX 24 AC6 ALA D 80 GLN D 84 5 5 HELIX 25 AC7 ASP D 96 ILE D 101 1 6 HELIX 26 AC8 ASP D 106 ASN D 116 1 11 HELIX 27 AC9 ASN D 121 ASN D 140 1 20 HELIX 28 AD1 ASP D 144 ASN D 162 1 19 CRYST1 73.010 75.876 110.803 90.00 90.00 90.00 P 21 21 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013697 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013179 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009025 0.00000